Cbot — Merger or Acquisition (June 2007)
20 slides from Cbot's merger presentation, Jun 26, 2007
Slide 1: CBOT/CME: A Combination to Compete Successfully in the Global Marketplace
CBOT/CME: A Combination to Compete Successfully in the Global Marketplace June 2007
Slide 2: Forward-looking statements and important merger information
JUNE 2007 Certain statements in this presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and includes any use of the words “may,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “pot
Slide 3: © Chicago Boardof Trade ST
© Chicago Boardof Trade ST
Slide 4: Transaction terms: dividend, exercise rights, closing, accretion
Dividend: Exercise Rights: Anticipated Closing: Expected Accretion: Consideration: Board of Directors: Pro Forma Ownership: All CBOT stockholders would receive a cash dividend of $9.14 per share of Class A common stock if the CBOT/CME merger closes The right to continue as a class member in the CBOE
Slide 5: Timeline
Timeline Oct. 17: Announce initial merger agreement March 15: Receive unsolicited proposal from ICE March 19: Boards authorize discussions with ICE Teams and processes established to review ICE bid Meetings and document review begin March 25-April 27: Thorough due diligence review of ICE, including
Slide 6: Factors Considered by Boards
Factors Considered by Boards Long term shareholder value Potential synergies Risks to franchise Integration and execution risk, especially clearing and technology Competitive dynamics Future growth opportunities and strategic fit Access to new products Globalization Customer and market Ability to cr
Slide 7: © Chicago Boardof Trade ST
© Chicago Boardof Trade ST
Slide 8: CME/CBOT: A Strategic Fit
CME/CBOT: A Strategic Fit Creates world’s largest futures exchange Clearly aligned with CBOT’s strategic vision Better positioned to pursue immediate and long-term growth opportunities Entails low integration and execution risk Generates substantial synergy potential
Slide 9: CME Combination Aligned with CBOT Strategic Vision
CME Combination Aligned with CBOT Strategic Vision Expands access to global markets Offers innovative new trading opportunities Enhances depth and breadth of liquidity that we provide the marketplace Provides long-term value to stockholders Ability to close deal quickly and focus on strategic growth
Slide 10: Better Positioned for Immediate and Long-Term Growth Opportunities
Can immediately pursue OTC growth opportunities Greater diversity of revenues Complementary products create opportunities for significant revenue/growth synergies Financials, equities and agricultural products Both organizations have proven track record of long-term growth Better Positioned for Imme
Slide 11: Entails Low Integration and Execution Risk
Entails Low Integration and Execution Risk Builds on strong productive relationship between CME and CBOT over many years CME and CBOT have proven track record in integration Successful integration of CCL in 9 months CME integration of NYMEX in 2 months Speed to integration Migration to Globex expect
Slide 12: Substantial Synergy Potential: Realizable & Certain
Cost synergies of $150 million already identified Includes technology, trading floor consolidation and administrative Expected to be accretive to earnings on a cash basis within 12 months and on a GAAP basis within 12-18 months Share repurchase expected to provide additional earnings accretion Oppor
Slide 13: Opportunities for Significant Revenue Synergies
Opportunities for Significant Revenue Synergies Cross-Selling • Product complementarities significantly increase cross selling opportunities Product Innovation • Yield curve products • Spread products/functionalities • Strong entry point for credit, corporate bond and cash treasury markets Large Sca
Slide 14: © Chicago Boardof Trade ST
© Chicago Boardof Trade ST
Slide 15: Combination with ICE Presents Significant Risks
Combination with ICE Presents Significant Risks Franchise Risk – Integration and Execution Electronic trading and clearing migration will take at least 24 months, with timeline labeled as “aggressive” and subject to “many risks” by CSC Consulting Expiration of existing service agreements not aligned
Slide 16: Integration Risk – Missed Opportunities
Integration Risk – Missed Opportunities Product development may be adversely affected during migration to ICE platform Loss of critical personnel anticipated during migration creates additional risk for business Protracted integration process would put CBOT at competitive disadvantage in a rapidly c
Slide 17: Significant Integration Risk with ICE
741 6,454 3,866 3,866 Significant Integration Risk with ICE… ICE’s current trading and clearing platforms do not have the capacity to serve our volume and business model ( i.e. , functionality) Necessary changes in these systems must be properly designed, funded and timely implemented Failure to ach
Slide 18: Equity Research Highlights the Strategic and Operational Advantages of a CME Transaction
Equity Research Highlights the Strategic and Operational Advantages of a CME Transaction . . . Howard Chen, Credit Suisse (May 30 – June 14) “ We ’ ve supported this deal given its strategic fit and more limited integration/execution risk – that hasn’t changed . ” “ Integration/execution risk remain
Slide 19: And Believes the CME Transaction Should Prevail
. . . And Believes the CME Transaction Should Prevail Edward Ditmire, Fox-Pitt (June 13) “We believe a minority of CBOT members are strictly focused on price, and ICE likely already had their support, but most are weighing integration risk against price, and this balan ce hasn't changed much. ” Niam
Slide 20: CME/CBOT: A Strategic Fit
CME/CBOT: A Strategic Fit Creates world’s largest futures exchange Clearly aligned with CBOT’s strategic vision Better positioned to pursue immediate and long term growth opportunities Entails low integration and execution risk Generates substantial synergy potential